Back to search
FDAFDA · Food and drugs·Recall number D-0003-2023

Aminophylline Injection, USP 250 mg/10 mL (25 mg/mL) 25x10 mL Single-dose vial, Rx only, Distributed by Hospira, Inc. Lake Forest, IL 60045 USA. NDC 0409-5921-16 (vial) 0409-5921-01 (carton)

Published October 12, 2022 · Recall initiated: September 27, 2022

Summary

FDA records drug Class II recall D-0003-2023, published October 12, 2022 and initiated September 27, 2022. Recalling firm: Pfizer Inc.; Status: Terminated; Reported quantity: 103,150 10 mL vials; Lot: Lot: 30-137-DK Exp. 1 DEC. 2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: A complaint was received for the presence of a hair in one vial.

What to do

Voluntary: Firm initiated · Letter

Get an email if AMINOPHYLLINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
AMINOPHYLLINE
Manufacturer
Pfizer Inc.
Distributor
Distributed in the United States and Puerto Rico.
Lot
Lot: 30-137-DK Exp. 1 DEC. 2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Aminophylline Injection, USP 250 mg/10 mL (25 mg/mL) 25x10 mL Single-dose vial, Rx only, Distributed by Hospira, Inc. Lake Forest, IL 60045 USA. NDC 0409-5921-16 (vial) 0409-5921-01 (carton) recalled?

Yes. FDA published recall D-0003-2023 on October 12, 2022. Reported hazard: Presence of Particulate Matter: A complaint was received for the presence of a hair in one vial.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: AMINOPHYLLINE.